Biocartis

Switzerland
Malters, Lucerne, Switzerland, CH-1015

Company profile

Biocartis company profile

Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.

Business identity

Contact email
[email protected]
Phone number
41 21 694 04 30
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$10M-$100M
Founded
2007-01-01, Year

Headquarters

Postal code
CH-1015
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$414.4M
Last funding
Grant / $1.4M / 2020-09-30
Last equity funding
Post IPO Equity / $94.8M
Investors
19
Lead investors
3
Founders
2
Articles
105
Exited on
2015-04-24

Founders and investors

Founders

Nader DonzelRudi Pauwels

Lead investors

Aescap VentureAgentschap Innoveren & OndernemenPMV Tina Fund

Investors

Advent Venture PartnersDebiopharm GroupNew RheinPhilipsWellcome Trust